What does the ILD Evaluation Panel (with ANCA) include?
It evaluates lung-related biomarkers and autoimmune antibodies, including ANCA, to assess interstitial lung disease.
Who should take this test?
Individuals with persistent cough, breathlessness, abnormal imaging, or suspected autoimmune-related lung disease.
How is the sample collected?
A standard blood sample is drawn for immunological and biochemical testing.
Can this panel detect autoimmune causes of ILD?
Yes, ANCA and other markers help identify autoimmune contributions to lung disease.
Is fasting required for this test?
Fasting is generally not necessary unless advised by your clinician.
How does Metropolis Healthcare perform the test?
The laboratory uses precise immunoassays and standardized protocols for accurate antibody and biomarker detection.
Can this test help monitor disease progression?
Yes, it can track biomarker changes over time to assess response to therapy or progression.
How long does it take to get results from Metropolis Healthcare?
Reports are typically available within the standard clinical laboratory turnaround time.